The road ahead for CLL care in sub-Saharan Africa

Characteristics of chronic lymphocytic leukemia in Senegal

10.1186/s12878-016-0051-y · doi-reference

TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing

10.1186/s13000-016-0550-y · doi-reference

Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia

10.1038/s41598-018-30330-y · doi-reference

Delays in seeking, reaching and access to quality cancer care in sub-Saharan Africa: a systematic review

10.1136/bmjopen-2022-067715 · doi-reference

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update

10.1038/s41375-024-02267-x · doi-reference

NCCN Guidelines(R) insights: chronic lymphocytic leukemia/small lymphocytic lymphoma, version 2.2026

10.6004/jnccn.2026.0012 · doi-reference

EHA guidelines on management of chronic lymphocytic leukemia and Richter transformation

10.1002/hem3.70403 · doi-reference

iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

10.1182/blood-2017-09-806398 · doi-reference

TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics

10.3324/haematol.2018.187583 · doi-reference

Bridging the diagnostic gap in CLL through TP53 molecular diagnostics in sub-Saharan Africa

10.1016/j.bglo.2026.100130 · doi-reference